121 related articles for article (PubMed ID: 3741433)
1. N-[(1,5,9)-trimethyl-decyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol a novel potent inhibitor of 2,3-oxidosqualene cycloartenol and lanosterol cyclases.
Taton M; Benveniste P; Rahier A
Biochem Biophys Res Commun; 1986 Jul; 138(2):764-70. PubMed ID: 3741433
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 2,3-oxidosqualene cyclases.
Taton M; Benveniste P; Rahier A; Johnson WS; Liu HT; Sudhakar AR
Biochemistry; 1992 Sep; 31(34):7892-8. PubMed ID: 1510977
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibition of animal and higher plants 2,3-oxidosqualene-sterol cyclases by 2-aza-2,3-dihydrosqualene and derivatives, and by other ammonium-containing molecules.
Duriatti A; Bouvier-Nave P; Benveniste P; Schuber F; Delprino L; Balliano G; Cattel L
Biochem Pharmacol; 1985 Aug; 34(15):2765-77. PubMed ID: 4015713
[TBL] [Abstract][Full Text] [Related]
4. Potent inhibition of cholesterol biosynthesis in 3T3 fibroblasts by N-[(1,5,9)-trimethyldecyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol, a new 2,3-oxidosqualene cyclase inhibitor.
Gerst N; Duriatti A; Schuber F; Taton M; Benveniste P; Rahier A
Biochem Pharmacol; 1988 May; 37(10):1955-64. PubMed ID: 3377803
[TBL] [Abstract][Full Text] [Related]
5. N-(1-oxododecyl)-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol: a potent competitive inhibitor of 2,3-oxidosqualene cyclase.
Wannamaker MW; Waid PP; Van Sickle WA; McCarthy JR; Wilson PK; Schatzman GL; Moore WR
J Med Chem; 1992 Sep; 35(19):3581-3. PubMed ID: 1404239
[No Abstract] [Full Text] [Related]
6. Inhibition of 2,3-oxidosqualene: beta-amyrin-cyclase, S-adenosyl-L-methionine: cycloartenol C-24-methyltransferase and cycloeucalenol: obtusifoliol isomerase by rationally designed molecules containing a tertiary amine function.
Rahier A; Bouvier P; Cattel L; Narula A; Benveniste P
Biochem Soc Trans; 1983 Oct; 11(5):537-43. PubMed ID: 6642064
[TBL] [Abstract][Full Text] [Related]
7. The squalene-2,3-epoxide cyclase as a model for the development of new drugs.
Cattel L; Ceruti M; Viola F; Delprino L; Balliano G; Duriatti A; Bouvier-Navé P
Lipids; 1986 Jan; 21(1):31-8. PubMed ID: 3515096
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives.
Viola F; Brusa P; Balliano G; Ceruti M; Boutaud O; Schuber F; Cattel L
Biochem Pharmacol; 1995 Sep; 50(6):787-96. PubMed ID: 7575639
[TBL] [Abstract][Full Text] [Related]
9. An alternative mechanism for the inhibition of cholesterol biosynthesis in HepG2 cells by N-[(1,5,9)-trimethyldecyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol (MDL 28,815).
Van Sickle WA; Wilson PK; Wannamaker MW; Cooper JR; Flanagan MA; McCarthy JR; Bey P; Jackson RL
J Pharmacol Exp Ther; 1993 Dec; 267(3):1243-9. PubMed ID: 8263786
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cholesterol biosynthesis in Chinese hamster ovary cells by 4,4,10 beta-trimethyl-trans-decal-3 beta-ol. A specific 2,3-oxidosqualene cyclase inhibitor.
Chang TY; Schiavoni ES; McCrae KR; Nelson JA; Spencer TA
J Biol Chem; 1979 Nov; 254(22):11258-63. PubMed ID: 500643
[No Abstract] [Full Text] [Related]
11. Inhibitory activity of 8-azadecalin derivatives towards 2,3-oxidosqualene:lanosterol cyclases from baker's yeast and pig's liver.
Hoshino T; Kobayashi N; Ishibashi E; Hashimoto S
Biosci Biotechnol Biochem; 1995 Apr; 59(4):602-9. PubMed ID: 7772824
[TBL] [Abstract][Full Text] [Related]
12. 2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors.
Cattel L; Ceruti M; Balliano G; Viola F; Grosa G; Rocco F; Brusa P
Lipids; 1995 Mar; 30(3):235-46. PubMed ID: 7791532
[TBL] [Abstract][Full Text] [Related]
13. Structural and stereoelectronic requirements for the inhibition of mammalian 2,3-oxidosqualene cyclase by substituted isoquinoline derivatives.
Barth MM; Binet JL; Thomas DM; de Fornel DC; Samreth S; Schuber FJ; Renaut PP
J Med Chem; 1996 Jun; 39(12):2302-12. PubMed ID: 8691425
[TBL] [Abstract][Full Text] [Related]
14. 2,3-Epoxy-10-aza-10,11-dihydrosqualene, a high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase.
Ceruti M; Balliano G; Viola F; Grosa G; Rocco F; Cattel L
J Med Chem; 1992 Aug; 35(16):3050-8. PubMed ID: 1501233
[TBL] [Abstract][Full Text] [Related]
15. 2,3-Oxidosqualene cyclase and cycloartenol-s-adenosylmethionine methyltransferase activities in vivo in the cotyledon and axis tissues of germinating pea seeds.
Fang TY; Baisted DJ
Biochem J; 1975 Sep; 150(3):323-8. PubMed ID: 1212194
[TBL] [Abstract][Full Text] [Related]
16. Effects of a 2,3-oxidosqualene-lanosterol cyclase inhibitor 2,3:22,23-dioxidosqualene and 24,25-epoxycholesterol on the regulation of cholesterol biosynthesis in human hepatoma cell line HepG2.
Dollis D; Schuber F
Biochem Pharmacol; 1994 Jul; 48(1):49-57. PubMed ID: 8043030
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 2,3-oxidosqualene-lanosterol cyclase in Candida albicans by pyridinium ion-based inhibitors.
Goldman RC; Zakula D; Capobianco JO; Sharpe BA; Griffin JH
Antimicrob Agents Chemother; 1996 Apr; 40(4):1044-7. PubMed ID: 8849227
[TBL] [Abstract][Full Text] [Related]
18. Differences in the inhibitory effects of N-(1-n-dodecyl)-heterocycles on the 2,3-oxidosqualene lanosterol-cyclase of rat liver and yeast.
Mercer EI; Morris PK; Baldwin BC
Comp Biochem Physiol B; 1985; 80(2):341-6. PubMed ID: 3884249
[TBL] [Abstract][Full Text] [Related]
19. Affinity labeling of vertebrate oxidosqualene cyclases with a tritiated suicide substrate.
Abe I; Bai M; Xiao XY; Prestwich GD
Biochem Biophys Res Commun; 1992 Aug; 187(1):32-8. PubMed ID: 1520315
[TBL] [Abstract][Full Text] [Related]
20. Plant oxidosqualene metabolism: cycloartenol synthase-dependent sterol biosynthesis in Nicotiana benthamiana.
Gas-Pascual E; Berna A; Bach TJ; Schaller H
PLoS One; 2014; 9(10):e109156. PubMed ID: 25343375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
